JOIN US FOR A LIVE VIRTUAL CME ACTIVITY
Next-Generation DMD Care:
Harnessing New Therapies and
Enhancing Patient Outcomes
Thursday, October 30, 2025
11:30am – 12:45pm Pacific Time
Join Emma Ciafaloni, MD, FAAN and Aravindhan Veerapandiyan, MD for this one-hour, live, virtual, interactive, case-based program designed to provide a comprehensive overview of current issues in the diagnosis and management of patients with Duchenne’s muscular dystrophy. It includes a patient perspective on living with the disease.
Target Audience
This activity is designed to meet the educational needs of healthcare providers involved in the diagnosis and care of patients with Duchenne’s muscular dystrophy (DMD), including neuromuscular specialists, general neurologists, physiatrists/rehabilitation medicine physicians, physical therapists, neurology advanced practice practitioners.
CME credit: 1.25 AMA PRA Category 1 Credits™
Educational Objectives
- Understand the genetic and molecular underpinnings of Duchenne muscular dystrophy
- Integrate expert-recommended diagnostic and therapeutic approaches in the management of Duchenne muscular dystrophy.
- Develop comprehensive patient care plans that focus on improving long-term health and quality of life
This activity is supported by an educational grant from Sarepta.
This activity is not part of the official AANEM program or endorsed by AANEM. The CME Institute of Physicians Postgraduate Press, Inc is responsible for all content and accreditation.
Register Now for the Live Virtual CME
Earn 1.25 AMA PRA Category 1 Credits™
Faculty
Emma Ciafaloni, MD, FAAN
Professor of Neurology, Pediatrics and Obstetrics and Gynecology
Director, Pediatric Neuromuscular Medicine University of Rochester
Aravindhan Veerapandiyan, MD
Associate Professor of Pediatrics, University of Arkansas for Medical Sciences College of Medicine
Director, Comprehensive Neuromuscular Program and Director, PPMD Certified Duchenne Care Center
Connect with us on LinkedIn